Illustration: Sarah Grillo/Axios
Ares Management plans to bring pharma consulting firm The Lockwood Group to market later this year, Axios Pro has learned.
Inside the room: Ares has yet to hire a sell-side advisor for the company, which will be marketed on about $70 million of EBITDA, two sources say.
